Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Heterogeneity of treatment effect of stress ulcer prophylaxis in ICU patients: A secondary analysis protocol

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Patterns of cerebral tissue oxygen tension and cytoplasmic redox state in bacterial meningitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Delirium assessment in neuro-critically ill patients: A validation study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Rebound pain following peripheral nerve block anaesthesia in acute ankle fracture surgery: An exploratory pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Association between perioperative hyperoxia and cerebrovascular complications after laparotomy-A post-hoc follow-up study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Bleeding and thrombosis in intensive care patients with thrombocytopenia-Protocol for a topical systematic review

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

BACKGROUND: In the Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) trial, 3291 adult ICU patients at risk for gastrointestinal (GI) bleeding were randomly allocated to intravenous pantoprazole 40 mg or placebo once daily in the ICU. No difference was observed between the groups in the primary outcome 90-day mortality or the secondary outcomes, except for clinically important gastrointestinal bleeding. However, heterogeneity of treatment effect (HTE) not detected by conventional subgroup analyses could be present.

METHODS: This is a protocol and statistical analysis plan for a secondary, post hoc, exploratory analysis of the SUP-ICU trial. We will explore HTE in one set of subgroups based on severity of illness (using the Simplified Acute Physiology Score [SAPS] II) and another set of subgroups based on the total number of risk factors for GI bleeding in each patient using Bayesian hierarchical models. We will summarise posterior probability distributions using medians and 95% credible intervals and present probabilities for different levels of benefit and harm of the intervention in each subgroup. Finally, we will assess if the treatment effect interacts with SAPS II and the number of risk factors separately on the continuous scale using marginal effects plots.

CONCLUSIONS: The outlined post hoc analysis will explore whether HTE was present in the SUP-ICU trial and may help answer some of the remaining questions regarding the balance between benefits and harms of pantoprazole in ICU patients at risk of GI bleeding. CLINICALTRIALS.

GOV REGISTRATION: NCT02467621.

Original languageEnglish
JournalActa Anaesthesiologica Scandinavica
ISSN0001-5172
DOIs
Publication statusE-pub ahead of print - 18 Jul 2019

ID: 57626789